SUBSCRIBERS
Brokers' take
Published Fri, Mar 2, 2018 · 09:50 PM
Singapore Medical Group > Buy DBS Group Research, March 2 March 2 close: S$0.55 Target price: S$0.73
WHILE Singapore Medical Group's (SMG) FY17 results came in lower than our expectations due to one-off costs as well as lower-than-expected health segment margins, the contribution
of earnings from three paediatric clinics in 2H17 and improving diagnostic business continued to help drive earnings in 2H17.
Copyright SPH Media. All rights reserved.